Clinical Trial Update: A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol. [Phase 3]

View source ↗

Summary

Phase 3 trial comparing multiple-dose tiotropium capsules with salmeterol inhalation aerosol in COPD patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• salmeterol inhalation aerosol (salmeterol)
• tiotropium inhalation capsules (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: COMPLETED